/
Electromed, Inc. ( we, our, us, Electromed or the Company ) develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest Airway Clearance System ( SmartVest System ) to patients with compromised pulmonary function with a commitment to excellence and compassionate service. Our goal is to make High Frequency Chest Wall Oscillation ( …
15.09% operating margin is respectable but not wide. ROIC at 15.70%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue up 17.0% YoY with margins expanding 3.1pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$72M
▲ +17.0% YoY
Net Income (TTM)
$10M
▲ +46.3% YoY
Op. Margin
18.25%
▲ +3.1pp YoY
ROIC
21.07%
▲ +4.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$10M
▲ +26.8% YoY
Op. Cash Flow (TTM)
$11M
▲ +25.7% YoY
Net Debt
-$17M
Net Cash Position
Cash & Equiv.
$17M
5Y CAGR: +14.5%
5Y CAGR: +27.1%
Continue Research